GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PhoenixBio Co Ltd (TSE:6190) » Definitions » Cyclically Adjusted Revenue per Share

PhoenixBio Co (TSE:6190) Cyclically Adjusted Revenue per Share : 円463.17 (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is PhoenixBio Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

PhoenixBio Co's adjusted revenue per share data for the fiscal year that ended in Mar. 2025 was 円381.060. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円463.17 for the trailing ten years ended in Mar. 2025.

During the past 12 months, PhoenixBio Co's average Cyclically Adjusted Revenue Growth Rate was 3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-07-22), PhoenixBio Co's current stock price is 円 400.00. PhoenixBio Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Mar. 2025 was 円463.17. PhoenixBio Co's Cyclically Adjusted PS Ratio of today is 0.86.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of PhoenixBio Co was 1.18. The lowest was 0.85. And the median was 1.09.


PhoenixBio Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for PhoenixBio Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhoenixBio Co Cyclically Adjusted Revenue per Share Chart

PhoenixBio Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 448.77 463.17

PhoenixBio Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 448.77 - 463.17

Competitive Comparison of PhoenixBio Co's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, PhoenixBio Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhoenixBio Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PhoenixBio Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PhoenixBio Co's Cyclically Adjusted PS Ratio falls into.


;
;

PhoenixBio Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PhoenixBio Co's adjusted Revenue per Share data for the fiscal year that ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=381.06/111.1000*111.1000
=381.060

Current CPI (Mar. 2025) = 111.1000.

PhoenixBio Co Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201603 470.433 97.900 533.862
201703 422.999 98.100 479.054
201803 311.053 99.200 348.367
201903 420.961 99.700 469.095
202003 447.240 100.300 495.397
202103 313.402 99.900 348.538
202203 401.217 101.100 440.902
202303 625.273 104.400 665.401
202403 453.549 107.200 470.049
202503 381.060 111.100 381.060

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


PhoenixBio Co  (TSE:6190) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PhoenixBio Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=400.00/463.17
=0.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of PhoenixBio Co was 1.18. The lowest was 0.85. And the median was 1.09.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


PhoenixBio Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of PhoenixBio Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PhoenixBio Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
3-4-1, Kagamiyama, Hiroshima Prefecture, Higashi-Hiroshima, JPN, 739-0046
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics related test, safety test, hepatitis virus (HBV / HCV) related drug efficacy test.

PhoenixBio Co Headlines

No Headlines